Frank Orlowski, Director, Business Development, is attending BioProcess International US West on March 15 – 17. As an attendee, he will have the opportunity to engage with 90+ speakers who will “present novel case studies, new data, and critical industry trends designed to accelerate biologics toward commercial success.”
Mr. Orlowski leads LBG’s business development. A former Pfizer executive, he worked for more than 25 years in positions of increasing responsibility in Finance, Strategy, and Operations. He led the Supply Chain and Finance functions across Asia, Eastern Europe, South America, and the Middle East, developing business, operational, and financial market access product localization strategies.
The conference focuses on “today’s latest innovations across all phases of biopharmaceutical development and manufacturing.”
